Momentum Continues as ResMed Unveils Multiple Product Initiatives and New Mask Technology
ResMed delivered another solid quarter with net income of USD 110.1 million on group revenue of USD 591.6 million, up 25% and 15% from the year-ago third quarter, respectively. Operating leverage was again a major factor with selling, general, and administrative expenses, and to a lesser degree research and development costs, trending down on a sequential basis. ResMed also unveiled several product initiatives, including the launch of a new smartphone app for screening sleep apnoea in China and ...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.